Compare PBH & MGNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PBH | MGNI |
|---|---|---|
| Founded | 1996 | 2007 |
| Country | United States | United States |
| Employees | N/A | 971 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.3B |
| IPO Year | 2004 | 2014 |
| Metric | PBH | MGNI |
|---|---|---|
| Price | $47.67 | $16.38 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $75.33 | $25.22 |
| AVG Volume (30 Days) | 774.2K | ★ 2.3M |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 493.75 |
| EPS | ★ 3.91 | 0.03 |
| Revenue | ★ $975,777,000.00 | $156,414,000.00 |
| Revenue This Year | N/A | $6.28 |
| Revenue Next Year | $4.31 | $9.76 |
| P/E Ratio | ★ $12.17 | $540.00 |
| Revenue Growth | ★ 36.77 | 25.45 |
| 52 Week Low | $42.62 | $10.82 |
| 52 Week High | $85.29 | $26.65 |
| Indicator | PBH | MGNI |
|---|---|---|
| Relative Strength Index (RSI) | 41.64 | 69.53 |
| Support Level | $44.51 | $15.77 |
| Resistance Level | $49.21 | $17.31 |
| Average True Range (ATR) | 1.55 | 0.72 |
| MACD | 0.49 | 0.19 |
| Stochastic Oscillator | 53.35 | 98.91 |
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Magnite is a supply-side advertising platform that provides technology and yield management solutions to content publishers, enabling them to monetize their digital advertising inventory. Magnite receives a percentage of all advertising inventory that it sells. 43% of Magnite's revenue is derived from connected television, or CTV, streaming platforms, 40% from mobile applications, and the remainder from general websites. Beyond the typical monetization responsibilities inherent to an SSP, Magnite also provides upstream advertising servers to CTV publishers, allowing them to have granular control over direct-sold, programmatic guaranteed, and open-auction logic. Magnite competes with other independent SSPs, supply path optimization solutions, and closed ecosystems like Meta.